Proactive Investors - GSK PLC (LON: GSK) announced positive results from a Phase III clinical trial, MATINEE, evaluating Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).

Read More »

A history of... GlaxoSmithKline

Assistant Editor, Hannah Blake, picks this series back up, starting here with the history of GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters ...

Read More »

With 86% institutional ownership, GSK plc (LON:GSK) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their ...

Read More »

GSK shares higher after Delaware Zantac ruling

GSK PLC (LON: GSK) shares opened higher after Delaware's Supreme Court said it will hear an appeal by the UK drug market and other pharmaceutical companies, ...

Read More »

GSK Shares Rise as Court Decision on Zantac Evidence Reviewed

GSK Plc shares rose on Wednesday, buoyed by a US court’s decision to review whether evidence supporting claims that heartburn drug Zantac causes cancer is scientifically sound.

Read More »